TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/11/2025
Back to search
Official data from USPTO
PLASMACELL XI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PLASMACELL XI
ST13
US500000086346702Class
9, 10
Filing
86346702
Registration
5617630
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
62
Latest update
07/16/2025
Trademark type
Word
Nice classes
9, 10
Filing date
07/24/2014
Registration date
11/27/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/07/2024
Last transaction
07/16/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/31/2017
First use in commerce
03/31/2017
Drawing code
4
Owner type
03
Owner location
Lake Zurich, IL
Examiner
FINK,GINA M
Current location
Historical data usage
Holders and representatives
Holders
Fenwal, Inc.
Representatives
Lee J. Eulgen NEAL GERBER & EISENBERG LLP
Technical classification
Nice Classes
Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
laboratory apparatus and instruments for separating constituents of bodily fluidsnot for medical purposes
Class 10
Apheretic apparatus and instruments for withdrawing whole bloodseparating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for separating constituents of bodily fluids; medical apheretic apparatus and instruments consisting primarily of plastic tubing and containers all sold as components of apheretic kits for withdrawing whole bloodseparating the blood into constituents and returning at least some of the constituents to the donor or patient; apparatus and instruments for separating constituents of bodily fluids consisting of plastic tubing and containers all sold as components of apheretic kits for withdrawing whole bloodseparating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for testing and treating blood; surgical and medical apparatus and instruments for withdrawing whole bloodseparating the blood into constituents and returning at least some of the constituents to the donor or patient; skins for medical apparatus and instrumentsprotective coverings for enclosing and/or sealing medical instruments; replacement parts for all of the aforesaid goods
Publications
History of USPTO decisions and trademark events.
62 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/11/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/07/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/07/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/07/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/22/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/27/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/27/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/20/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/19/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/27/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/26/2018
EX5G
SOU EXTENSION 5 GRANTED
07/26/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/26/2018
EXT5
SOU EXTENSION 5 FILED
07/19/2018
EEXT
SOU TEAS EXTENSION RECEIVED
07/19/2018
EISU
TEAS STATEMENT OF USE RECEIVED
07/19/2018
IUAF
USE AMENDMENT FILED
07/18/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/23/2018
EX4G
SOU EXTENSION 4 GRANTED
01/19/2018
EXT4
SOU EXTENSION 4 FILED
01/19/2018
EEXT
SOU TEAS EXTENSION RECEIVED
01/19/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/27/2017
EX3G
SOU EXTENSION 3 GRANTED
06/23/2017
EXT3
SOU EXTENSION 3 FILED
06/23/2017
EEXT
SOU TEAS EXTENSION RECEIVED
06/23/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/06/2017
EX2G
SOU EXTENSION 2 GRANTED
01/04/2017
EXT2
SOU EXTENSION 2 FILED
01/04/2017
EEXT
SOU TEAS EXTENSION RECEIVED
01/04/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/10/2016
EX1G
SOU EXTENSION 1 GRANTED
05/06/2016
EXT1
SOU EXTENSION 1 FILED
05/06/2016
EEXT
SOU TEAS EXTENSION RECEIVED
05/06/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/19/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/24/2015
PUBO
PUBLISHED FOR OPPOSITION
11/24/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/04/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/22/2015
ALIE
ASSIGNED TO LIE
10/15/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/15/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
09/15/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/15/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
09/15/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/15/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/12/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/01/2015
GNFR
FINAL REFUSAL E-MAILED
05/01/2015
CNFR
FINAL REFUSAL WRITTEN
05/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/22/2014
GNRT
NON-FINAL ACTION E-MAILED
09/22/2014
CNRT
NON-FINAL ACTION WRITTEN
09/22/2014
DOCK
ASSIGNED TO EXAMINER
09/19/2014
MPMK
NOTICE OF PSEUDO MARK E-MAILED
08/02/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2014
NWAP
NEW APPLICATION ENTERED
07/28/2014
Continuous trademark protection
Get notified about every new filing that threatens PLASMACELL XI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.